Correlation Between Allogene Therapeutics and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Hookipa Pharma, you can compare the effects of market volatilities on Allogene Therapeutics and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Hookipa Pharma.
Diversification Opportunities for Allogene Therapeutics and Hookipa Pharma
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Allogene and Hookipa is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Hookipa Pharma
Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Hookipa Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Allogene Therapeutics is 1.17 times less risky than Hookipa Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Hookipa Pharma is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 950.00 in Hookipa Pharma on August 25, 2024 and sell it today you would lose (735.00) from holding Hookipa Pharma or give up 77.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Allogene Therapeutics vs. Hookipa Pharma
Performance |
| Timeline |
| Allogene Therapeutics |
| Hookipa Pharma |
Allogene Therapeutics and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Hookipa Pharma
The main advantage of trading using opposite Allogene Therapeutics and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Hookipa Pharma vs. Eliem Therapeutics | Hookipa Pharma vs. HCW Biologics | Hookipa Pharma vs. RenovoRx | Hookipa Pharma vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |